Tokyo, Dec. 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059748) titled 'Clinically Significant Outcomes, Disease Burden, Treatment and Management in Fibrosing Interstitial Lung Disease in Japan- A National Database Study' on Dec. 1.
Study Type:
Observational
Primary Sponsor:
Institute - Nippon Boehringer Ingelheim Co., Ltd
Condition:
Condition - IPF, PPF, and non-progressive ILD
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To investigate the cumulative incidences of clinically significant outcomes such as mortality (including lung transplantation), all cause hospitalisation, respiratory hospitalisation, and acute exacerbation in pat...